Updates in endoscopic bariatric and metabolic therapies.
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The rising prevalence of obesity, and related morbidity and mortality, has necessitated the development of therapeutic weight loss strategies. Lifestyle modifications alone have only yielded modest benefit, and while bariatric surgery has shown significant short- and long-term results, only a minority of eligible patients end up receiving this treatment. Endoscopic bariatric and metabolic therapies (EBMTs) are a rapidly evolving field, which provides a less invasive middle ground treatment option for weight loss. Here we discuss the efficacy, as well as short- and long-term outcomes with restrictive, malabsorptive/metabolic and aspiration endoscopic techniques, and their effects on metabolic parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adverse effects include nausea/vomiting (20%) and abdominal pain (7%).118”
From Obesity Management in Adults: A Review (2023) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O’Brien, P. E., Hindle, A., Brennan, L., Skinner, S., Burton, P., Smith, A., Crosthwaite, G., & Brown, W. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3525-0 · Cited by 815 · cited 1×
“The EBMT procedures can largely be subdivided into restrictive, malabsorptive/metabolic and aspiration techniques depending on their target [8].”
BackgroundPeterli, R., Steinert, R. E., Woelnerhanssen, B., Peters, T., Christoffel-Courtin, C., Gass, M., Kern, B., von Fluee, M., & Beglinger, C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0622-3 · Cited by 529
Abu Dayyeh, B. K., Kumar, N., Edmundowicz, S. A., Jonnalagadda, S., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1964 · Cited by 469 · cited 3×
“In three randomized controlled trials (RCTs) comparing Orbera balloon placement to controls, % EBWL was 26.9% (95% CI, 15.6 – 38.2; p ≤ 0.01) [7].”
BackgroundMethodInfluentialAssociation of body mass index with health care expenditures in the united states by age and sex
Ward, Z. J., Bleich, S. N., Long, M. W., & Gortmaker, S. L. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247307 · Cited by 428 · cited 1×
“As such, obesity and its complications have been recognized as a public health crisis and concerted efforts targeting development of preventive and treatment strategies is ongoing [2,3].”
BackgroundAbu Dayyeh, B. K., Bazerbachi, F., Vargas, E. J., Sharaiha, R. Z., Thompson, C. C., Thaemert, B. C., Teixeira, A. F., Chapman, C. G., Kumbhari, V., Ujiki, M. B., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01280-6 · Cited by 338 · cited 1×
“All were successfully treated [25].”
Abu Dayyeh, B. K., Acosta, A., Camilleri, M., Mundi, M. S., Rajan, E., Topazian, M. D., & Gostout, C. J. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.030 · Cited by 305
Efficacy and Safety of Endoscopic Sleeve Gastroplasty: A Systematic Review and Meta-Analysis
Hedjoudje, A., Abu Dayyeh, B. K., Cheskin, L. J., Adam, A., Neto, M. G., Badurdeen, D., Morales, J. G., Sartoretto, A., Nava, G. L., Vargas, E., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.022 · Cited by 266 · cited 1×
“The pooled adverse event rate was 2.2% [23].”
BackgroundInfluentialShort-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients
Alqahtani, A., Al-Darwish, A., Mahmoud, A. E., Alqahtani, Y. A., & Elahmedi, M. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.12.012 · Cited by 207 · cited 1×
“These hormonal changes are thought to contribute to a higher weight loss observed with LSG compared to ESG, because even though ESG mimics LSG in terms of anatomic alterations it does not seem to reproduce the same hormonal changes [30,35,36].”
BackgroundThompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.500 · Cited by 201 · cited 2×
“Serious adverse effects are rare, including peritonitis and prepyloric ulceration or tube removal [50].”
Backgroundvan Baar, A. C. G., Holleman, F., Crenier, L., Haidry, R., Magee, C., Hopkins, D., Rodriguez Grunert, L., Galvao Neto, M., Vignolo, P., Hayee, B., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318349 · Cited by 201
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Nduma, B. N., Mofor, K. A., Tatang, J., Amougou, L., Nkeonye, S., Chineme, P., Ekhator, C., & Ambe, S. (2023) · Cureus · doi:10.7759/cureus.41466 · Cited by 12
“(2023) [17] Whereas the total body weight loss in the ESG group was documented to be lower than that in the LSG group, the rate of adverse events in the ESG group was established to be more promising.”
BackgroundFrom pathophysiology to novel approaches for obesity-associated hypertension
Kanbay, M., Yayci, E., Genc, C., Çöpür, S., Aktaş, Ö. Y., Sarafidis, P. A., Covic, A. C., Ortíz, A., & Laffin, L. J. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf218 · Cited by 11
“Endoscopic gastric plication, gastric aspiration, duodenal mucosal resurfacing, endoscopic anastomosis systems and endoscopic bypass liners are other potential endoscopic bariatric procedures with limited clinical experience [113 ].”
Abaalkhail, F. A., Sanai, F. M., Alswat, K., Alzanbagi, A., Al-Jedai, A. H., Alshehri, A., Alfadda, A. A., Alghamdi, H., Almadi, M. A., AlEissa, M., et al. (2025) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_199_25 · Cited by 12
A commentary review on endoscopic sleeve gastroplasty: Indications, outcomes and future implications
Abuawwad, M., Tibude, A., Bansi, D. S., IDRIS, I. R., & Madhok, B. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15613 · Cited by 9
“4,9,48 Nduma et al. published a systematic review of 20 studies confirming a superior safety profile of ESG, including a lower risk of de-novo gastric oesophageal reflux disease (GORD), whereas SG resulted in a higher weight loss and a higher chance of remission of obesity-related comorbidities.”
Background
Metadata
- Authors
- Qureshi, H., Saeed, N., & Jovani, M.
- Affiliations
- University of Kentucky (US)
- Maimonides Medical Center (US)
- Corresponding author
- Jovani, Manol
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-01-31
- Volume
- 12
- Issue
- 3
- Pages
- 1126
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9917553
- OpenAlex
- W4319795290
- Cited by
- 21
- References
- 64
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 2 · 2023: 4
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- endoscopic bariatric therapy, obesity, weight loss, metabolic parameters, long-term outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Updates in endoscopic bariatric and metabolic therapies. https://app.cochat.ai/papers/10.3390/jcm12031126
- The paper
- Qureshi, H., Saeed, N., & Jovani, M. (2023). Updates in endoscopic bariatric and metabolic therapies. Journal of Clinical Medicine. https://doi.org/10.3390/jcm12031126
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.